• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    METHOD OF OBTAINING 1-
    公开号:SU1143315A3
    申请号:SU823381951
    申请日:1982-02-03
    公开日:1985-02-28
    发明作者:Ашванден Вернер；Кибурц Эмилио
    申请人:Ф.Хоффманн-Ля Рош Унд Ко,Аг (Фирма)；
    IPC主号:
    专利说明:

    I t1 carbonyl group - by catalytic hydrogenation (for example, on Pd / C), trichloro- and tribromoethoxycarbonyl group - by zinc and copper in glacial acetic acid at room temperature and the benzoyl formyl group with aqueous pyridine at room temperature. Suitable as R protective groups are, for example, easily cleavable alkyls, such as tert, butyl, and the like, easily cleavable aral reals, such as benzyl, and the like, easily blessed acyls, such as fluoroenes :: carbonyl, benzylcarbonyl, trichloroethyl sicarbonyl, tribromoethoxycarbonyl, etc. Examples of the compound of formula (I) can be: 1- (3-hydroxy-4-methoxybenzoyl) -2-oxo-3-pyrrolidinyl acetate (A) i 1- (3-.benzyloxy-4-methoxybenzoyl) 3-hydroxy- 2-pyrrole, inon (6), 3- (benzyloxycarbonyloxy) -1- (3benzyloxy-4-methoxybenzoyl) -2-pyrrolidinone (C), 1- (3-benzyloxy-4-methoxybenzoyl) 2-oxo-3-pyrrolidinyl trifluoroacetate (D) i 1- (3-Benzyloxy-4-methoxybenzoyl) 2-oxo-3-pyrrolidinyl acetate (E). Compound A is a compound of formula (IaZ, where R is acetyl. This compound can be converted with esterase enzymes to a compound of formula (I). Compound B is a compound of formula (If), where R is benzyl. This is the compound by catalytic hydrogenation (for example, on Pd / C) can be converted to a compound of formula (I). Compound C is a compound of formula (IIc), where R is benzyloxycarbonyl and benzyl, and compound G is a compound of formula (He), where R is triphospacesI and R is benzyl, and the compound is a compound of formula (11c), where R is acetyl and R is benzyl. Compound C is an example of a compound of formula (PS), which can be converted into a compound of formula (1) in a single operation by cleaving both protective groups. J3To is catalytic rj oxidation, for example, on Pd / C Compound B is an example of a compound of formula (He), which can be converted into a compound of formula (2) in two steps. For example, cleavage of the trifluoroacetyl group with methanol from compound D first produces compound B, which in turn is catalytic hydri Hovhan (e.g., Pd / C) is transferred into a compound of formula (I), Compound E is another example of compound (used), which two operations of the translated to a compound of formula (I). Thus, for example, cleavage of benzyl by cat hydrogenation (for example, on Pd / C) first gives compound A, which, in turn, is converted into compound (1) using esterase enzymes. The starting compounds of formula (II) are new. The compounds of formula (I), where R and each means a protecting group, i.e. compounds of the general formula (PS) can be obtained, for example, by the fact that the pyrrolidine derivative of the general formula r-Y N 0. H where R3 has the indicated value, is acylated appropriately at position 1, i.e. the hydrogen atom in position 1 of the compound of formula (III) is replaced by a suitably substituted benzoyl residue. In this case, it is possible to use known acylation methods. As an acylating agent, a sufficiently reactive derivative of an acid of the formula soon CHjO de R can be specified, in particular, a reactive imiazolide or anhydride such an acid (for example, 3-benzyloxy-4-methoxybenzoyl chloride). In case of such acylation, it is expedient to first treat the compound of formula (W) with a base, remove the hydrogen atom from the nitrogen atom in position 1, for example, with utilization, and then react it with reactive kis (IV), but it is possible to use I114 (III) in the form of a reactive derivative, in which the nitrogen atom in position 1 has an easily detachable group, in particular a trialkylsilyl group, for example, 1-trimethylsilyl. In this case, only residues that are not affected under the acylation conditions can be used as protective groups (R). Compounds (III) are prepared, for example, from 3-hydroxy-2-pyrrolidinone by introducing the desired protecting group. Ways to the introduction of protective groups should be selected depending on the nature of the latter. For example, the bennloxy carbonyl group can be introduced by means of the benzyl ester of chloroformic acid. Some compounds of the general formula (III) can also be obtained from 4-amino-oxybutyric acid by means of methods which ensure cyclization and the introduction of the desired protecting group in one operation. For example, one can obtain 3- (trimethylsilyoxy) 2-pyrrolidinone by reacting 4-amino-2-hydroxy acid in the presence of insignificant amounts of trimethylchlorosilane with hexamethyldisilazane or bis (trimethylsil-1) urea or bis (Trimethylsilyl) acetamide. On the other hand, it is possible to obtain compounds of the formula (He) from the linkage of the general formula of the general formula OH CO —H — CH 2 —CH — CH 2 —COOH where R has the indicated value, which, in turn, are available as a result of 4-amino acid acylation 2-butyric acid with a reactive derivative of the acid of formula (IV), for example, 3-benzyloxy-4-labels sibenzoyl chloride. Thus, for example, the treatment of 4 (3-benzyloxy-4-meth6xybenzoyl) amino -2-hydroxybutyric acid with acetic acid hydride in one operation simultaneously provides both cyclization and the introduction of a protective group, i.e. obtaining the compound (He), where R is benzyl and R is acetyl. Examples of other reagents, with which in one operation 4-0 3 benzyloxy-4-methoxybenzoyl) amino 2-hydroxybutyric acid or another compound of formula (V) can be converted into (tie), are anhydrides of chloro-, methoxy-, trifluoroacetic acid, hexamethyldisilazane, etc. In accordance with the reagent used in the resulting compound of formula (He), R is chloroacetyl, or methoxyacetyl, or trifluoroacetyl, or trimethylsilyl, or t .P. It is possible to cyclize derivatives of the compound (V), whose hydroxyl group is protected, to the corresponding compound (He). In order to obtain the derivatives of compound (V), they are derived from 4-amino-2-hydroxybutyric acid derivatives, the hydroxyl group of which is already protected by a protective group and which can be easily obtained by known methods, and acylating their amino group with a sufficiently reactive derivative of compound (IV). Compounds (He) and (Hb) are obtained by cleaving one of the protecting groups from the corresponding compound (Hp). Thus, compound E of formula (He), where R3 is acetyl and R-benzyl, can be converted into compound A by hydrogenation in the presence of Pd / C, i.e. to compound (Na), where R is acetyl. Further, compound D of formula (He), where R is trifluoroacetyl and R is benzyl, can be converted into compound 6 with methanol, i.e. in the compound of formula (P), where R is benzyl. The compounds of general formula (H) in position 3 of the five-membered heterocycle have an asymmetric atom C. The stereochemical relations in this heterocycle determine the stereochemical relations in the compound of formula 1, i.e. in 1- (3-hydroxy-4-methoxybenzoyl) 3-hydroxy-2-pyrrolidinone, obtained from compound (P). The stereochemical relations in the 5-membered heterocycle position of the compound (H), in their own form, are .l processors and / or methods used in obtaining compounds of formula (H). Optically active or racemic 1- (3-hydroxy-4-methoxybenzoyl) -3oxy-2-pyrrolidinone can be obtained by the following method. CR) -1- (3-hydroxy-4-methoxybenzoyl) 3-hydroxy-2-pyrrolidinone can be obtained, for example, by acylation of (| 1) -4-amino-2-hydroxy acid with 3-benzyloxy-4-methoxybenzoyl chloride, 7114 the translation of the obtained (R) -4-C (3-benzyl oxy-4-methoxybenzoyl) amino7-2-oxo-methyl acid to (E) -1- (3-benzyloxy-4-methoxybenzoyl) -2-hydroxy-3pyrrolidinyl trifluoroacetate using trifluoroacetic anhydride, cleaving tri (fluoroacetyl) from the indicated acid, followed by benzyl removal from (P) -1- (3-benzyloxy-4-methoxybenzoyl) -3-hydroxy-2-pyrrolidinone obtained. Similarly, (8) is obtained -1- (3-hydroxyA-methoxybenzoyl) -3-hydroxy-2-pyrrolidinone starting from (8) -4-amino-2-hydroxy-butyric acid and (K, 5) -1- (3-hydroxy4- methoxybenzoyl) -3-hydroxy-2-pyrrolidine starting from (K, 8) -4-amino-2-hydroxy acid. The pyrrolidine derivative of formula (1) is a new compound with very valuable pharmacological properties, which has only minor toxicity. In the experiment with animals, it has been established that it is able to counteract artificially induced cerebral insufficiency. Experimental apparatus is a box with trifed trellised bottom (30x40 cm) and gray plastic platform (15x15x0.8 cm) in the right front corner. Male rats (100-120 g) are separately placed on the platform. As soon as they are lowered onto the slatted bottom, their paws are subjected to electric current (0.8 mA). Usually the rats jump back onto the platform, but they try to descend to the lattice several times. It is necessary to repeat the effect of electric current another 3-5 times. Only after 3-5 repetitions, the rats will learn to give a so-called passive avoidant response, i.e. they no longer try to descend into the lattice. Immediately thereafter, three groups of 30 animals each form. The first group is injected intraperitoneally with 0.3 mg / kg of scopolamine and distilled water (2 ml / kg orally) is administered. The second group is injected with 0.3 mg / kg of scopolamine and orally withdrawn the test substance. The third group is given only distilled water. After 2 hours, each rat is once placed on the crate platform. The criterion for evaluating this experiment is to determine the effect of preparation 8 for a short time. memory, is that the animal will stay for 6v) on the platform or not (the result for each animal can only be yes or no). The statistically characteristic difference between the obtained results of the first and second groups is determined using the Tc (chi-square) experiment. 70-75% of animals that received only distilled water, 24 hours after the training, the reactions still know that they must remain on the platform. In 85-92% of animals that received scopolamine and distilled water, a retrograde effect on short-term memory, i.e. animals forget that they must remain on the platform. A substance that counteracts brain deficiency is able to remove (blocking short-term drugs caused by injecting 0.3 mg / kg of scopolamine. The dose of the drug is considered active relative to scopolamine if the number of positive results (yes) is significantly different from the number of positive control results animals that received scopolamine and only distilled water.The table indicates the doses at which the racemate and both optically homogeneous enantiomeric forms of the compound of formula (1) are is a significant activity in the described experience. The table also provides data on acute toxicity (DLuo I with a single oral administration of mice). R Continuation of the tables 1- (| 1-methoxybenzoyl) -2-pyrrolidinone (analog) Compound of formula (I) can directly It can be administered orally, for example, in the form of t-tapes, varnish tablets, dragees, hard and soft gelatin capsules of solutions, emulsions or suspensions, or rectally, for example, in the form of suppositories, or parenterally, for example, in the form of solutions for injections . The S-enantiomer of the compound of formula (I) exhibits, at lower doses, a greater activity than the analog, and that the R-enantiomer and racemate of the compound of formula (I) show significant activity not only at lower doses, but within wider limits dosage than analog. The proposed compound of formula (}) can be used to prevent and combat cerebral insufficiency, as well as to improve intellectual disability, for example, in the case of cerebral insults, in geriatrics, alcoholism, etc. The dosage of the drugs can vary widely and in each case is determined by the individual condition of the patient. When administered orally, a daily dose of 10-2500 mg of the compound of formula (1) can be applied, and, if necessary, the upper dosage limit can be exceeded. A.L. Example A. To 4.3 g of (R, S) -4-amino-2-hydroxy butyric acid in 80 ml of deionizir bath water, stir well, add 20.0 g of 3-benzyloxy. -4-me toxibenzoyl chloride and 20 ml of tetrahydrofuran (THF), then the mixture obtained is brought to a pH of 10.5 with 2 n solution of caustic soda and kept at a pH of 180 min by adding an appropriate amount of 2 n of caustic soda. The slurry is then filtered, and then ice is added to the filtrate. The pH of the filtrate is adjusted to 1 with 25% hydrochloric acid. The precipitated solid is filtered, washed with water, dried and milled, after which 800 ml of methylene chloride are added and the mixture is heated for 1 hour at reflux temperature. The insoluble fraction of (R, S) -4-P (3-benzyloxy-4-methoxybenzoyl) amino-3-hydroxybutyric acid is filtered and washed with methylene chloride. By concentrating the filtrate, a certain amount of (R, S) -4-L (3-benzyl-4-methoxybenzoyl) amine -2-hydroxy acid of the acid is obtained, m.p. 140-141 ° C. Yield 84%. B. 4.0 g of (R, S) -4- (3-benzyl-4-methoxybenzoyl) amine -2-hydroxybutyric acid and 0.55 g of sodium trifluoroacetate in 24 ml of trifluoroacetic anhydride are heated for two days with stirring at reflux temperature. After evaporation of the reaction mass, the residue is shaken 4 times with toluene, and then toluene is evaporated in vacuo. The residue containing (R, S) -1- (3-benzyl-4-methoxybenzoyl) -2-hydroxy-3-pyrrolidinyl trifluoroacetate is heated to abs. For 30 minutes. methanol at reflux. After evaporation of the methanol, acetic acid ethyl ester and water were added to the residue. The insoluble solid was filtered to give (R, S) -1- (3benzyloxy-4-methoxybenzoyl) -3-oxy2-pyrrolidinone, m.p. 182-183 p. Another portion of this product with the same melting point is separated from the organic phase of the filtrate. Yield 70%. B. 1.8 g of (R, S) -1- (3-benzyl-4-methoxybenzoyl) -3-hydroxy-2-pyrrolidinone is dissolved in 70 ml of THF and hydrogenated with 1.5 g of 5% Pd / C with hydrogen. at atmospheric pressure. After filtration of the catalyst and concentration of the filtrate, the residue is stirred in diethyl ether at room temperature. The solid is filtered. And thus (R, S) -1 (Zgoxi-4-methoxybenzoyl) -3-hydroxy-2-pyrrolidinone is obtained with a mp. 131-132 ° C. Yield 91%.,. PRI me R 2.
    A.4.6 g of (R, S) -4- (3-benzyloxyA-methoxybenzoyl) amino J-2-hydroxy acid is heated in 12 ml of acetic anhydride for 15 minutes at reflux temperature. After evaporation of the reaction mixture, the residue was shaken 6 times with toluene, and then toluene was evaporated under vacuum. Receive (K, 5) -1- (3-benzpoksi-4-methoxybenzoyl) -2-hydroxy-3-pyrrolidishe acetate with so pl. 140-141 s. Yield 94%.
    B. 4.60 g of (E, 5) -1- (3-benzyloxy4-methoxybenzoyl) -2-hydroxy-3-pyrrolidinyl acetate in 100 ml of acetic acid is hydrogenated with 2.0 g of 5% Pc) / C with hydrogen at atmospheric pressure. After filtration of the catalyst and evaporation of the acetic acid under vacuum stirring with diethyl ether, (R, S) -1- (3-hydroxy-4-methoxybenzoyl) -2-hydroxy-3-pyrrolynyl acetate are obtained, m.p. 141-142 0. 75% 75%.
    B. To 0.50 g of ground (R, S) 1- (3-hydroxy-4-methoxybenzoyl) -2-hydroxy-3-pyrrolidinyl acetate in 20 ml of 0.05 molar buffer consisting of potassium and sodium phosphate, with a value of
    pH 6.61 was added 1710 el. esterase enzyme (carboxylic ester hydrolysis), then stirred for 195 minutes at room temperature and the insoluble content is filtered. The filtrate is stirred for another 135 mi at room temperature and then extracted with ethyl acetate. The acetic phase is washed with water. The aqueous phases are further extracted with ethyl acetate. The collected acetic ether extracts are dried with sodium sulfate, filtered and evaporated. A two-dimensional TLC residue shows the presence of (K, 5) -1- (3-hydroxy-4-methoxybenzoyl) -3-hydroxy-2-pyrrolidinone. Vcode 20-35%.
    Example 3
    A. 6.0 g of (I, 8) -3-hydroxy-2-yrrolidinone are dissolved in 120 ml of pyridine, then at 0-5 24 ml of benzyl chloroformate are added and the mixture is stirred for 22 hours at room temperature. The reaction mixture is evaporated, the residue is then stirred with toluene, and again evaporated. The residue is dissolved in ethyl
    ester of acetic acid and water. The organic phase is washed with water and the aqueous phases are further extracted with ethyl acetate. The collected ethyl acetate phases are dried with sodium sulfate and evaporated. The crystalline residue is dissolved in 700 ml of dioxane at reflux temperature and maintained at + 5 °. Receive (K, 5) -3- (benzyloxycarbonyloxy) -2-pyrrolidinone c. m.p. 81-82 C. Yield 79%.
    B. 5.0 g (E, 8) -3- (benelloxycarbonyloxy) -2-pyrrolidinone is silylated in THF with trimethylchlorosilane and triethylamine. Receive (K, 8) -3- (benzyloxycarbonyloxy) -1-trimethylsilyl-2-pyrrolidinone with so pl. 56-58 ° C. Yield 86%.
    B. 3.30 g of (K, 8) -3- (benzyloxycarbonyloxy) -1-trimethylsilyl-2-pyrrolidinone is mixed with 2.97 g of 3-benzyloxy-4-methoxybenzoyl chloride, then stirred at room temperature. Then the trimethyldichlorosilane formed is distilled off under reduced pressure in an oil bath (U & C). The residue is dissolved in ethyl acetate and water. The organic phase is treated with active charcoal, dried with sodium sulfate and ground. After stirring the residue in diethyl ether, (R, S) -3- (benzyloxycarbonyloxy) -1- (3-benzyloxy-4-methoxybenzonl) 2-pyrrolidinone is obtained, m.p. 125-126 pp. -Exit 68%.
    D. 3.0 g of (K, 5) -3- (benzyloxycarbonyloxy) -1- (3-benzyl-4-methoxybenzoyl) -2-pyropolydinone is hydrogenated in 60 ml of THF per 1.5 g of 5% Pd / C hydrogen at atmospheric pressure. After filtration of the catalyst and concentration of the filtrate, (R, S) -1 - (3-hydroxy-4-methoxybenzoyl) 3-hydroxy-2-pyrrolidinone is obtained, which, after stirring with diethyl ether, melts at 125-126 ° C. The yield is 92%.
    Example4.
    A. K 4.3 g (R) -4-amino-2-hydroxy oil
    20.0 g of 3-benzyloxy-4-methoxybenzoyl chloride and 20 ml of THF are added with vigorous stirring to 80 ml of deionized water with vigorous stirring. Then 2 n. pH is adjusted with caustic soda solution. mixtures up to 10.5 and over 200 minutes by adding 2. caustic soda solution maintain the mixture at this pH value. The slurry is then filtered, ice is added to the filtrate and the pH is adjusted to 1.4 with 25% hydrochloric acid. The precipitated solid is filtered off, washed with deionized water, dried and chromatographed on 90 g of silica gel (grain size 0.2-0.5 mm). Elution of ethyl acetate with acetic acid is almost pure (K) -4- (3-benzyloxy-4-methoxybenzoyl) -amine J-2-hydroxybutyric acid, after recrystallization from acetonitrile, has a melting point of 138-140 0. The yield is 55%. B. 5.0 g (R) -4- (3-benzoxy-4-metoxybenzoyl I) amine} -2-oximetric acid and 0.70 g of sodium trifluoroacetate in 30 ml of trifluoroacetic anhydride for two days with stirring and boiling under reflux . After evaporation of the reaction mass, the residue is shaken 3 times with toluene, after which the toluene is evaporated under vacuum. The residue containing (K) -1- (3-benzyloxy-4-methoxyben-zoyl) -2-hydroxy-3-pyrrolidinyl trifluoroacetate is heated to abs. methanol 30 min at reflux temperature. After evaporation of the methanol, acetic acid ethyl ester was added to the residue. Insoluble fractions are filtered and after recrystallization from ethyl acetate (p / p. hexa. on poluchayag (s) -1- {3-benzyloxy. "±". П: 4-methoxybenzoyl) -3-hydroxy-2-pyrrolidone non with so pl. 164-166 C.Uf if: + 143% 54t- + 177, l «i (5 + 866 ° 0; lorofo pm with 1.0). Yield 57%. B. 2.20 g of (K) -1- (3-benzsh10ksi-4methoxybenzoyl) -3-hydroxy-2-pyrrolidine in 60 ml of THF is hydrogenated with 1.80 g of 8% PJ / C with hydrogen at atmospheric pressure. After filtration of the catalyst, concentration of the filtrate and 15% recrystallization of the residue from ethyl acetate / hhexane, (K) -1- (3-hydroxy-4-m-toxi-benzoyl) -3-hydroxy-2-pyrrolidinone, m.p. 129-131 С.. + 175 20,. „, 0. Ch-45g (chloroform (| °, .- H216Moi (, f. S 1.0). Yield 90%. EXAMPLE 5 A To 5.06 g of (8) -4-amino-2-hydroxybutyric acid in 130 ml of deionized water with vigorous stirring was added 15.5 g of 3-benzyloxy-4methoxybenzoyl chloride and 20 ml of THF. Then, by 2N solution caustic soda the pH of the mixture is adjusted to 10.5 and 180 min by the addition of 2 n sodium hydroxide solution and the mixture is kept at this pH.The suspension is then filtered and ice is added to the filtrate, the pH is set to 25% hydrochloric acid 4 and extracted with ethyl acetate. Ostoato after evaporation of the extract, boil in 240 ml of methylene chloride at reflux temperature. Insoluble (S) -4-C (3-benzyloxy-4-methoxybenzoyl) amino -2-hydroxybutyric acid is filtered after recrystallization from acetonitrile, it melts at 138-140 ° C Yield 60%. B. 6.5 g of (S) -4-t (3-benzoxy-4-methoxybenzoyl) amine -2-hydroxybutyric acid and 1, O g of sodium trifluoroacetate in 40 ml of trifluoroacetic anhydride with stirring is boiled two days at reflux temperature. After evaporation of the reaction mass, the residue is shaken three times with toluene, and the toluene is then evaporated under vacuum. The residue, containing (8) -1- (3-benzyloxy-4-methoxybenzoyl) -2-hydroxy-3-pyrrolidinyl trifluoroacetate, in 40 ml of abs . methanol is boiled for 30 minutes at reflux temperature. Then it is stirred for another 1 h at room temperature, the solid is filtered and washed with met. (5) -1- (3-benzyl-Si-4-methoxybenzoyl) -3-hydroxy-2-pyr- is obtained. rolidinone, which after recrystallization from methanol, melts at 166-167 ° C. (if | j °: -146 °, (: - 180, (879 ° (chloroform, s 1.0). Yield 58%. V. 2, 40 g of (8) -1- (3-benzyloxy-4methoxybenzoyl) -3-hydroxy-2-pyrrolidinone is hydrogenated in 100 ml of THF with 2.00 g of 5% Pd / C with hydrogen at atmospheric pressure. the catalyst, the concentration of the filtrate and recrystallization from ethyl acetate and diethyl ether give (8) -1- (3-hydroxy-4-methoxybenzoyl) -3-hydroxy-2-pyrrolidinone Or. I / 1 2c, opja I /, 20 pp. 131-132 ° C.); - 180% U /;; -233 ", | оC / D 1-464, (chloroform, s 1.0). Output 83%. Characteristic. (K , 8) -1- (3-hydroxy-4-methoxybenzoip: 5 3-hydroxy 2-pyrrolidinone (examples 1-3). 151 Elemental analysis of C.5H "NO (251.2А) Calculated: C 57.37; H 5 , 22; N 5.5 Found: C 57.31i H 5.51; N 5.59 IR (KBr), 3358, 3410 (OH), 2843 (OCH), 1745 (C 0.5-ring amide ), 1692, 1708 (amide), 1530, 1606 and 1635 (, aroma.) 1218, 1237, 1259 and 1279 (aryl ether). NMR. (80 MHz, B-DMSO) (ppm): 9.20 ( with; BUT aroma.) I 6.9-7.2 (m ЗН aroma} 5.8 (width НО) j-4,164, 54 (t-CHj -CH-C0-) l 3.86, (s, СН, - 0), 3.3-3.9 (m, -CHj-N), 1.62, 5 (m, -CHj-CH-OH). The corresponding (R) -e, nantiomer (example 4). Elementary analysis :. (251.24) Calculated: C 57.37-, H 5.22; N5.58 Found: C 57.51; H 5.31-, N 5.55 The NMR spectrum is identical to the NMR spectrum of the racemate. IR spectroscopy is not performed. The corresponding (5) enantiomer is imer 5). Elementary analysis: i (251.24) Calculated: C 57.37 H 5.22; N 5.58 Found: C 57.74; H 5.42; N 5.59 The NMR spectrum is identical with NMR spectromate.
    权利要求:
    Claims (1)
    [1]
    METHOD FOR PRODUCING 1- (3-OXY4-MET0XIBEN30IL) -3-Oxy-2-pyrrolidinone of the formula (I)
    OH • rt
    I optically, in the form of racemate isomers, the fact that the protective groups of the general group of the pyrrolidinone derivative of the formula (II) are removed
    N where one of the radicals' R ’is a protecting group and the other is hydrogen or a protecting group, the protecting group being an acyl or aralkyl group, followed by incorporation of the desired product as a racemate or optically active isomers.
    >
    1 1143315
    类似技术:
    公开号 | 公开日 | 专利标题
    SU1143315A3|1985-02-28|Process for producing 1-|-3-oxy-2-pyrrolidinon
    US5319098A|1994-06-07|Process for the stereoselective preparation of L-alanyl-L-proline
    US5346907A|1994-09-13|Amino acid analog CCK antagonists
    CA1144931A|1983-04-19|Pyroglutamic acid derivatives and analogs
    Fleet et al.1988|Synthesis from D-mannose of 1, 4-dideoxy-1, 4-imino-L-ribitol and of the α-mannosidase inhibitor 1, 4-dideoxy-1, 4-imino-D-talitol
    CA1083585A|1980-08-12|Preparation of pyrrolidine derivatives
    US4221789A|1980-09-09|Lactam-N-acetic acids and their amides
    JP2691442B2|1997-12-17|Novel proline derivative
    Langlois et al.1996|Enantioselective syntheses of |-3-phenyl GABA,|-baclofen and 4-arylpyrrolidin-2-ones
    CA1126728A|1982-06-29|Pyrrolo or pyrido ¬2,1-c|¬1,4| thiazinesor thiazepines
    GB2225322A|1990-05-30|The preparation of S-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
    Yakura et al.2007|Synthesis of an immunomodulator |-conagenin and its analogs
    WO2008103382A1|2008-08-28|Method for assembling high-purity chemical libraries, compounds suppressing acetyl coenzyme a carboxylase activities discovered by same
    Seki et al.2004|A practical synthesis of |‐biotin from L‐cysteine
    FI70572B|1986-06-06|FOERFARANDE FOER FRAMSTAELLNING AV FARMACEUTISKT ANVAENDBARA PYRROLIDINDERIVAT SAMT VID DERAS FRAMSTAELLNING ANVAENDBARA FOERENINGAR
    US4822895A|1989-04-18|3-aminoazetidine, its salts and intermediates of synthesis
    DE69630184T2|2004-08-12|Process for the preparation of 1-substituted pyrrole-3-carboxylic acid derivatives
    CA2266565C|2002-03-05|Azabicyclic rotomase inhibitors
    Maison et al.1999|Synthesis of novel pipecolic acid derivatives: a multicomponent approach from 3, 4, 5, 6-tetrahydropyridines
    US4937355A|1990-06-26|Process for preparing |-4-substituted-dl-proline derivatives
    US5929242A|1999-07-27|Manufacture of levobupivacaine and analogues thereof from L-lysine
    Kotapati2017|Synthesis and Catalytic Evaluation of Novel C-Alpha-Methylbeta-Proline Analogues, and Concise Synthetic Approach to NH-Fmoc-S-Trityl-C-Alpha-Methyl Cysteine
    Hermann1990|Synthetic applications of the aza-Achmatowicz rearrangement
    Robotti1980|Peptide Functional Group Interactions in Synthetic Approaches to Cyclopeptide Alkaloids
    Berger1984|The Synthesis of Homaline
    同族专利:
    公开号 | 公开日
    EP0057846A1|1982-08-18|
    ES8304545A1|1983-03-16|
    IT8219115D0|1982-01-14|
    IE52439B1|1987-10-28|
    GB2092584B|1984-08-01|
    NZ199624A|1984-12-14|
    IL64896A|1985-07-31|
    AT13668T|1985-06-15|
    NO820346L|1982-08-06|
    AU552063B2|1986-05-22|
    IE820249L|1982-08-05|
    JPH0354097B2|1991-08-19|
    RO83099B|1984-02-28|
    NL8200337A|1982-09-01|
    RO83099A|1984-02-21|
    PT74387A|1982-03-01|
    CS227035B2|1984-04-16|
    JPS57146753A|1982-09-10|
    SE8200647L|1982-08-06|
    ZA82608B|1982-12-29|
    US4452807A|1984-06-05|
    GB2092584A|1982-08-18|
    EP0057846B1|1985-06-05|
    AT377982B|1985-05-28|
    BR8200615A|1982-12-14|
    LU83923A1|1983-09-02|
    PL135221B1|1985-10-31|
    AR231127A1|1984-09-28|
    IL64896D0|1982-03-31|
    AU8010482A|1982-08-12|
    GR76052B|1984-08-03|
    OA07002A|1983-08-31|
    HU184988B|1984-11-28|
    FR2499075A1|1982-08-06|
    ZW1982A1|1982-09-01|
    IS2700A7|1982-08-06|
    PH18267A|1985-05-14|
    FI820192L|1982-08-06|
    DE3202281A1|1982-09-16|
    ES509312A0|1983-03-16|
    MC1440A1|1982-12-06|
    CH646149A5|1984-11-15|
    PT74387B|1984-10-22|
    YU23982A|1985-03-20|
    KR830009023A|1983-12-17|
    DK20682A|1982-08-06|
    ATA41882A|1984-10-15|
    DD202539A5|1983-09-21|
    IT1153402B|1987-01-14|
    BG36932A3|1985-02-15|
    CA1158250A|1983-12-06|
    DE3263960D1|1985-07-11|
    PL234962A1|1982-09-27|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    ES433723A1|1975-01-10|1976-11-16|Lafarquim S A Lab|Procedure for obtaining a derivative of 2-pirrolidinone. |
    IT1045043B|1975-08-13|1980-04-21|Isf Spa|PYROLIDINE DERIVATIVES|
    CA1115212A|1978-02-10|1981-12-29|Emilio Kyburz|Pyrrolidine derivatives|
    CU21107A3|1978-02-10|1988-02-01|Hoffmann La Roche|DERIVATIVE PYRROLIDINES|
    CA1124247A|1979-08-09|1982-05-25|Hoffmann-La Roche Limited|Pyrrolidine derivatives|FR2515179B1|1981-07-24|1985-01-18|Hoffmann La Roche|
    FR2551751B1|1983-09-12|1986-04-25|Serobiologiques Lab Sa|NOVEL PROCESS FOR PREPARING A PYROGLUTAMIC DERIVATIVE, NOVEL PYROGLUTAMIC DERIVATIVES, NOVEL SYNTHESIS FOR PREPARING THE SAME AND USE OR APPLICATION OF PYROGLUTAMIC DERIVATIVES AS ANTIBACTERIAL OR ANTIFUNGAL AGENTS|
    DE3336024A1|1983-10-04|1985-04-18|Boehringer Ingelheim KG, 6507 Ingelheim|4-AMINO-L-BENZYL-PYRROLIDINONE AND ITS ACID ADDITION SALTS, METHOD FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS|
    DE3632589A1|1985-10-18|1987-04-23|Bayer Ag|METHOD FOR PRODUCING-BUTYROLACTAMES|
    DE3537075A1|1985-10-18|1987-04-23|Bayer Ag|METHOD FOR PRODUCING CLAUSENAMIDE|
    US4677114A|1985-11-22|1987-06-30|Warner-Lambert Company|Pyrrolidone-2 derivatives and pharmaceutical compositions thereof|
    IT1215587B|1987-06-26|1990-02-14|Roussel Maestretti Spa|DERIVATIVES OF 1-BENZOIL2-OXO 5-ALCOSSI PIRROLIDINA, THEIR PREPARATION PROCEDURE AND THEIR USE AS A MEDICINAL SUBSTANCE.|
    JPH0720930B2|1988-07-09|1995-03-08|明治製菓株式会社|Pyrrolidinone compound and cerebral dysfunction improving agent|
    US5049577A|1990-01-29|1991-09-17|E. R. Squibb & Sons, Inc.|2-pyrrolidone substituted dihydroxy alkanoic, alkenoic and alkynoic acids, compositions and HMG-CoA reductase inhibition therewith|
    US5049578A|1990-03-09|1991-09-17|E. R. Squibb & Sons, Inc.|1-aroyl or 1-acyl-2-2pyrrolidinyl-3,5-dihydroxy alkanoic and alkenoic acids, salts, esters and lactones|
    DK1156043T3|1992-07-24|2004-03-01|Univ California|Drugs that enhance synaptic responses mediated by ampa receptors|
    US5852008A|1995-01-24|1998-12-22|The Regents Of The University Of California|Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    CH77081A|CH646149A5|1981-02-05|1981-02-05|PYRROLIDINE DERIVATIVE.|
    [返回顶部]